The Vision Council promotes digital eye strain precaution at CES

Article

Las Vegas, NV-Last week, The Vision Council attended the 2014 International Consumer Electronics Show (CES) in Las Vegas to help users protect their eyes from digital eye strain, a growing health concern for avid electronic consumers.

Findings of a report examining the impact of digital media on vision health reveal that nearly 70% of U.S. adults experience digital eye strain while on devices such as computers, tablets, and smartphones. Yet, almost half of adults don't know how to or have never tried to reduce their visual discomfort.

In an effort to educate avid digital device users, The Vision Council connected with CES attendees about the benefits of computer glasses and coatings, demonstrating the latest in computer eyewear technology and teaching additional ways for individuals to minimize digital eye strain.

"Digital devices are an important part of our everyday lives, as evidenced by the incredible innovations displayed at CES," said Ed Greene, CEO of The Vision Council. "While our eyes are not ideally equipped to look at digital screens for extended periods of time, there are simple precautions that can prevent the discomfort that many Americans experience while using popular devices-and allow us to continue using these technologies without the risk of digital eye strain."

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.